Edit |   |
---|---|
Antigenic Specificity | CCL11, Human (Bertilimumab biosimilar) |
Clone | Bertilimumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FCM, IP, ELISA, Neut, FuncS |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CCL11 Recombinant Antibody. Bertilimumab is a human monoclonal antibody that binds to eotaxin-1, an important regulator of overall eosinophil function.It was discovered by Cambridge Antibody Technology using their phage display technology. Named CAT-213 during early discovery and development by CAT, it was to be used to treat severe allergic disorders. |
Immunogen | n/a |
Other Names | Anti-CCL11 Recombinant Antibody, Research Grade Bertilimumab, Anti-Human CCL11 Recombinant Antibody, CAT-213, iCo-008, Antibody Drug Analogues, Monoclonal Antibody, YR1106, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 375348-49-5 |
Catalog # | YR1106 |
Price | please inquire |
Order / More Info | CCL11, Human (Bertilimumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |